Skip to main content

Christine M. Lovly, M.D., Ph.D.

  • Co-Leader, Translational Research and Interventional Oncology Research Program
  • Assistant Professor of Medicine (Hematology/Oncology)

Phone

(615) 936-3457

Email

christine.lovly@Vanderbilt.Edu
Vanderbilt-Ingram Cancer Center
2220 Pierce Ave South
777 Preston Research Building
Nashville, TN 37232

Christine M. Lovly, M.D., Ph.D.

  • Co-Leader, Translational Research and Interventional Oncology Research Program
  • Assistant Professor of Medicine (Hematology/Oncology)

(615) 936-3457

christine.lovly@Vanderbilt.Edu

Vanderbilt-Ingram Cancer Center
2220 Pierce Ave South
777 Preston Research Building
Nashville, TN 37232

Profile

Christine Lovly, M.D., Ph.D., is a physician-scientist with a special interest in thoracic malignancies. Dr. Lovly's clinical practice focuses primarily on the care of patients with lung cancer. Her laboratory research is directed at understanding and developing improved therapeutic strategies for specific clinically relevant molecular subsets of lung cancer.

She received a B.A. in chemistry from Johns Hopkins University followed by M.D. and Ph.D. degrees as part of the Medical Scientist Training Program at Washington University in St. Louis, MO. She then completed internal medicine residency and medical oncology subspecialty training at Vanderbilt University. During her final year of fellowship, she was the Jim and Carol O'Hare Chief Fellow. She started on faculty at Vanderbilt in the Department of Medicine, Division of Hematology-Oncology in July 2012.

Dr. Lovly has received independent grant funding from Uniting Against Lung Cancer and the Conquer Cancer Foundation of the American Society of Clinical Oncology. She is the author of several peer-reviewed scientific manuscripts, and she is an active member in the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (IASLC), and the American Association for Cancer Research (AACR). She is also deputy editor for the website <a href="https://www.mycancergenome.org/">My Cancer Genome</a>, a Vanderbilt initiated, freely available website which aims to provide health care practitioners, patient, and advocates with up-to-date information regarding genetically informed cancer medicine.

Education

  • M.D., Washington University, Saint Louis, Missouri (2006)
  • Ph.D., Washington University, Saint Louis, Missouri (2006)
  • B.A., Johns Hopkins University, Baltimore, Maryland (1997)

Postgraduate Training

  • Resident in Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN (2006-2008)
  • Clinical Fellow in Hematology and Oncology , Vanderbilt University School of Medicine, Nashville, TN (2008-2012)
  • Jim and Carol O'Hare Chief Fellow in Hematology-Oncology, Vanderbilt University School of Medicine, Nashville, TN (2011-2012)

    Research Emphasis

    Lung Cancer, EGFR , ALK, kinase fusions, acquired resistance, targeted therapies, tyrosine kinase inhibitors (TKIs), genomics, EGFR mutation, Small Cell Lung Cancer, Liquid Biopsies, Structural Biology, Precision Medicine

    Research Description

    Publications

    Have any questions? Contact Us 1-877-936-8422 for more information